BioLineRx to Report First Quarter 2024 Results on May 28, 2024

Go back to BioLineRx to Report First Quarter 2024 Results on May 28, 2024
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.21 +0.01 (0.45%)
Previous Close $2.20    52 Week High $1.63 
Open $2.21    52 Week Low $0.71 
Day High $2.21    P/E N/A 
Day Low $2.21    EPS $0.00 
Volume 1,464       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.21 +0.01 (0.45%)
Previous Close $2.20    52 Week High $1.63 
Open $2.21    52 Week Low $0.71 
Day High $2.21    P/E N/A 
Day Low $2.21    EPS $0.00 
Volume 1,464